AD

(4S,5R,6R,14R)-4,5,6-Trihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0~1,5~.0~10,12~]pentadeca-2,7-dien-12-yl laurate(CAS: 54706-70-6)

(4S,5R,6R,14R)-4,5,6-Trihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0~1,5~.0~10,12~]pentadeca-2,7-dien-12-yl laurate
CAS Number

Related Products

Other Suppliers for (4S,5R,6R,14R)-4,5,6-Trihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0~1,5~.0~10,12~]pentadeca-2,7-dien-12-yl laurate

Basic Information

Molecular Formula
C32H50O7
Molecular Weight
546.75 g/mol
Physical State
Powder

Physical Properties

Density
1.19±0.1 g/cm3 (20 ºC 760 Torr),

Chemical Identifiers

SMILES
CCCCCCCCCCCC(O[C@@]12C[C@@H](C)[C@]3(C=C(C)[C@@H]4O)[C@]4(O)[C@H](O)C(CO)=C[C@@](C3=O)([H])[C@]1([H])C2(C)C)=O
InChIKey
FEZDDYPHEHMXLF-LKSMBHMZSA-N

Database References

MDL Number
MFCD30478893

FAQ

Regulatory guidelines for (4S,5R,6R,14R)-4,5,6-Trihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0~1,5~.0~10,12~]pentadeca-2,7-dien-12-yl laurate (CAS: 54706-70-6) include GHS classification, REACH regulations, and FDA/EPA related requirements. It is advisable to consult the latest regulatory databases and guidelines from relevant authorities for specific compliance requirements.
Yes, there are alternatives such as isomers and analogs of (4S,5R,6R,14R)-4,5,6-Trihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0~1,5~.0~10,12~]pentadeca-2,7-dien-12-yl laurate (CAS: 54706-70-6) that can be synthesized using different reagents and methodologies. Common alternatives include the use of similar functional groups or structural modifications to achieve similar or improved properties.
The market and research trends for (4S,5R,6R,14R)-4,5,6-Trihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0~1,5~.0~10,12~]pentadeca-2,7-dien-12-yl laurate (CAS: 54706-70-6) are focused on its potential applications in pharmaceuticals and cosmetics due to its specific structural characteristics. Recent research trends include exploring its bioavailability and therapeutic potential.
Waste containing (4S,5R,6R,14R)-4,5,6-Trihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0~1,5~.0~10,12~]pentadeca-2,7-dien-12-yl laurate (CAS: 54706-70-6) should be collected and handled in accordance with GHS guidelines. Proper incineration or professional waste disposal is recommended, with necessary precautions to prevent environmental pollution. Consult local regulations for specific disposal methods and safety measures.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

hepeng20160718@foxmail.com

Mobile

13122891558

Telephone

186-16545970